Sign Up to BioTechniques free email alert service to receive content updates.
G Protein-Coupled Receptors in Drug Discovery
Date: March 17, 2010
Location: MARITIM proArte Hotel, Berlin, Germany.

Informa Life Sciences’ 8th Annual:

G Protein-Coupled Receptors in Drug Discovery

17-18 March 2010 - Maritim proArte Hotel - Berlin - Germany
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Informa Life Sciences’ 8th Annual
G Protein-Coupled Receptors in Drug Disovery
17-18 March 2010  |  Maritim proArte Hotel, Berlin, Germany
Website: http://www.iir-events.com/IIR-Conf/page.aspx?id=24868&vip=[LabelCode]
Brochure: http://www.iir-events.com/IIR-Conf/page.aspx?id=24868&vip=[LabelCode]
Request Brochure by email: mailto:naomi.gill@informa.com
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
** Book by Friday 12th February 2010 quoting CQTTBIOT to save up to £300 on Industry Places **

Join us in 2010 – key programme highlights:
With no less than 56 international GPCR experts, this year’s congress features the latest developments in understanding biased agonism, predicting novel ligands from new x-ray structures, developing allosteric modulators for GPCRs, recent findings from the deophanisation project, feedback on novel approaches to in silico modelling for receptor activation and industry feedback on successful proof of concept studies.

Exclusive presentations for 2010 include:

  1. A potential new first-in-class treatment: Discovery of lorcaserin, a selective serotonin 5-HT2C agonist, for the treatment of obesity - Dr. Dominic Behan, Senior Vice President & Chief Scientific Officer, Arena Pharmaceuticals Inc., UK
  2. A successful proof of concept study: The novel antidepressant and melatonergic agonist/5-HT2C antagonist, agomelatine: From the cell to the clinic - and back - Dr. Mark Millan, Director, Neuropharmacology Division, Institut de Recherche Servier, France
  3. Predicting novel ligands from x-ray structures: A new approach to drug discovery utilising stabilised GPCRs - Dr. Fiona H. Marshall, Chief Scientific Officer, Heptares Therapeutics Ltd, UK.

Book NOW to Save up to £300 – simply:
- Email: mailto:registrations@informa-ls.com
- Telephone +44 (0) 207 017 7481
- Book online at: http://www.iir-events.com/IIR-Conf/page.aspx?id=24868&vip=[LabelCode]
Don’t forget to book before Friday 12th February 2010 quoting CQTTBIOT to save up to £300 on Industry places!

Contact: